This project will provide novel data using a large cohort of more than 3000 transplanted patients. Risk and protective factors for SARS-CoV-2 infection and COVID-19 disease severity will be identified. The proportion of patients who develop antibodies after infection will be revealed. In this way the presence of these antibodies can be evaluated as a test for prior infection. Our study additionally will demonstrate how long these antibodies remain present and whether they are protective against a new infection.
Diagnostic Test: SARS-CoV-2 IgG
Collection of clinical variables, assessment of IgG antibodies for SARS-CoV-2, plasma collection for translational immunology studies
Inclusion Criteria:
- all patients who underwent solid organ or hematopoietic cell transplantation at UZ
Leuven and who give informed consent
Exclusion Criteria:
- age under 18 years
UZ Leuven
Leuven, Vlaams Brabant, Belgium
Investigator: Jef Verbeek, MD
Contact: +32 16 345845
jef.verbeek@uzleuven.be
Investigator: Jef Verbeek, MD
Jef Verbeek, MD, PhD
+ 32 16 34 42 25
jef.verbeek@uzleuven.be
Natalie Van den Ende
+32 16 340749
natalie.vandenende@uzleuven.be
Jef Verbeek, MD, PhD, Principal Investigator
UZ Leuven